Tablo Announces $76.5M Investment.
*Bringing its total to $185.5M, Outset Medical announces a new investment from T. Row Price Associates. The Tablo machine is rethinking HD technology from the ground up. A minifridge-sized unit can purify tap water, send and receive data, and even clear air bubbles from the dialyzer and bloodlines.
Read the full article » | Posted 06-12-2017
Related Articles
- eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant Posted 09-15-2025
- The First Artificial Kidney Built in Canada has Ties to London: A Revolution in Care for Patients with Kidney Failure Posted 09-15-2025
- Fresenius Shares 5 Ways Artificial intelligence is Helping Dialysis Care Posted 08-21-2025
- HD with Saline and No Blood Thinner? Posted 06-11-2025